메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Shin, Dae-Hwan (National Research Laboratory [NRL] of PK/PD, CBITRC, Biotechnology Research Institute, College of Pharmacy, Chung-buk National University) Choi, Kyu-Seok (National Research Laboratory [NRL] of PK/PD, CBITRC, Biotechnology Research Institute, College of Pharmacy, Chung-buk National University) Cho, Byung-Suk (National Research Laboratory [NRL] of PK/PD, CBITRC, Biotechnology Research Institute, College of Pharmacy, Chung-buk National University) Song, Suk-Gil (National Research Laboratory [NRL] of PK/PD, CBITRC, Biotechnology Research Institute, College of Pharmacy, Chung-buk National University) Moon, Dong-Cheul (National Research Laboratory [NRL] of PK/PD, CBITRC, Biotechnology Research Institute, College of Pharmacy, Chung-buk National University) Hong, Jin-Tae (National Research Laboratory [NRL] of PK/PD, CBITRC, Biotechnology Research Institute, College of Pharmacy, Chung-buk National University) Lee, Chong-Kil (National Research Laboratory [NRL] of PK/PD, CBITRC, Biotechnology Research Institute, College of Pharmacy, Chung-buk National University) Chung, Youn-Bok (National Research La)
저널정보
대한약학회 Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 제31권 제10호
발행연도
2008.1
수록면
1,347 - 1,353 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
A 1:1 mixture of acriflavine (ACF; CAS 8063-24-9) and guanosine is under evaluation in preclinical studies as a possible antitumor agent. Guanosine is known to potentiate the anti-cancer activity of ACF. We therefore investigated the pharmacokinetics of guanosine following administration of the ACF/guanosine mixture in rats. Rats were given guanosine (1 or 5 mg/kg) or ACF/guanosine (2 or 10 mg/kg) by i.v. bolus; or guanosine (3 or 15 mg/kg) or ACF/guanosine (6 or 30 mg/kg) by i.m. injection. We found that guanosine was rapidly cleared from the blood and transferred to tissues after i.m. administration of ACF/guanosine. The mean plasma half-lives ($t_{1/2}$) at the $\alpha$ and $\beta$ phases were 0.091 and 6.86 h, or 0.092 and 7.51 h at a dose of 1 or 5 mg/kg guanosine, respectively. ACF had no effect on the plasma disappearance of guanosine following either i.v. bolus or i.m. administration of the combination mixture. Moreover, the ACF combination with guanosine did not significantly alter the values of MRT, $V_{dss}$. and $CL_t$ of guanosine. Guanosine exhibited linear pharmacokinetics over the dose range from 1 to 5 mg/kg for i.v. doses and 3 to 15 mg/kg for i.m. doses. The bioavailability of guanosine after i.m. administration was 84% for 3 mg/kg dose and 88% for 15 mg/kg dose. ACF had no effects on biliary and urinary excretion of guanosine after i.m. administration. The cumulative amount of guanosine in urine after i.m. administration was about 5-fold larger than that in bile, indicating that guanosine is mostly excreted into the urine. Guanosine was widely distributed in all tissues examined in this study, but was most highly concentrated in the kidney after i.m. administration, followed by slow excretion to bile or urine. ACF had no effect on the tissue distribution of guanosine following i.m. administration. These characterizations of the pharmacokinetics of guanosine after administration of the ACF/guanosine combination will be useful in providing preclinical and clinical bases for the potential application of this combination to the treatment of cancer.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0